Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

Background: We investigated patterns of gonadotropin-releasing hormone (GnRH) analogue use in castration-resistant prostate cancer (CRPC) using real-world data from six countries. Patients and methods: Data were obtained from Guy’s and St Thomas’ NHS Foundation Trust (GSTT, UK), Prostate Cancer data...

Full description

Saved in:
Bibliographic Details
Main Authors: G. George, D. Enting, H. Garmo, P. Stattin, I.F. Lissbrant, M. Monroy-Iglesias, L.-M. Scailteux, F. Balusson, C. Van Praet, N. Lumen, G. Marvaso, G. Corrao, B.A. Jereczek-Fossa, L. Chehade, A. Shamseddine, M. Charafeddine, M. Van Hemelrijck
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:ESMO Real World Data and Digital Oncology
Subjects:
castration-resistant prostate cancer
GnRH analogues
real-world data
cohort
prostate cancer treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2949820125000116
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2949820125000116

Similar Items